REGN holders · BlackRock Finance, Inc. 13F · REGN stock
BlackRock Finance, Inc. Regeneron Pharmaceuticals Inc (REGN) 13F holding
BlackRock Finance, Inc. reported 3,219,606 REGN shares valued at $3.38T as of 2024-06-30 (COM). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2024-06-30 | 3,219,606 | $3.38T | COM |
| 2024-06-30 | 2,322,002 | $2.44T | COM |
| 2024-06-30 | 936,975 | $984.79B | COM |
| 2024-06-30 | 250,694 | $263.49B | COM |
| 2024-06-30 | 247,764 | $260.41B | COM |
| 2024-06-30 | 240,348 | $252.61B | COM |
| 2024-06-30 | 177,386 | $186.44B | COM |
| 2024-06-30 | 177,346 | $186.40B | COM |
| 2024-06-30 | 164,249 | $172.63B | COM |
| 2024-06-30 | 147,001 | $154.50B | COM |
| 2024-06-30 | 137,975 | $145.02B | COM |
| 2024-06-30 | 116,124 | $122.05B | COM |
| 2024-06-30 | 103,153 | $108.42B | COM |
| 2024-06-30 | 92,550 | $97.27B | COM |
| 2024-06-30 | 33,112 | $34.80B | COM |
| 2024-06-30 | 28,466 | $29.92B | COM |
| 2024-06-30 | 22,689 | $23.85B | COM |
| 2024-06-30 | 15,551 | $16.34B | COM |
| 2024-06-30 | 6,382 | $6.71B | COM |
| 2024-06-30 | 5,181 | $5.45B | COM |
| 2024-06-30 | 1,812 | $1.90B | COM |
| 2024-03-31 | 3,314,695 | $3.19T | COM |
| 2024-03-31 | 2,334,567 | $2.25T | COM |
| 2024-03-31 | 869,603 | $836.98B | COM |
Not investment advice. Cached 13F row, not EDGAR XML.